Program description and target audience
The CoxHealth Heart and Vascular Summit delivers evolving, evidence-based principles for the best practice management of the cardiovascular patient. Explore current recommendations, emerging technologies, and state-of-the-art diagnostic and treatment modalities with topics that include: new approaches to old diseases, atrial fibrillation treatment and anticoagulation therapies, a retrospective look at the first 100 CoxHealth TAVR procedures, emerging heart failure therapies, what we have learned from the “Real Trial” and cardiovascular diseases in the diabetic population, minimally invasive therapies for peripheral artery and vascular disease, and effective solutions for managing the rapid changes in healthcare with cardiovascular market trends presented by The Advisory Board.
By attending this educational activity participants should be able to integrate some or all of the objectives as listed.
Friday, November 17, 2017
|Cardiovascular Market Trends
Speaker: Stuart Clark, Advisory Board
|1:45pm-3:15pm||Retrospective Review of TAVR and Patient Testimonial
Speakers: Dr. Steven Rowe and Rhonda James, RN
Speaker: Dr. Steven Kuehn
|5:00pm-6:00pm||Social Hour: Wonders of Wildlife Museum|
Saturday, November 18, 2017
|7:30am-8:30am||CVD REAL Study
Speakers: Dr. Sarah Billings, Clinical Pharmacist; Jordan Rowe and Brandi Bowers, Pharmacy Residents
|8:30am-10:00am||Peripheral Artery Disease
Speakers: Dr. Randy Mullins, Dr. Zak Schmittling, and Dr. Robert Vorhies
|10:00am– 10:15 am||Break/Vendor Displays|
|10:15am– 11:15am||New Twists to Old Disease, 2017 Cardiovascular Disease Update
Speaker: Dr. Sridevi Pitta
|11:15am- 12:15pm||Atrial Fibrillation
Speaker: Dr. John Garner
|12:15-12:30pm||Evaluations/Statements of Credit/ Adjourn|
We reserve the right to substitute speakers and topics in the event of emergency or cancellation. Information presented during this conference represents the views and opinions of the presenters and does not necessarily constitute the opinion, endorsement of, or promotion by CoxHealth. Presenters are responsible for obtaining all copyright permissions.
No off-label medications or medical devices will be discussed.
CoxHealth is accredited by the Missouri State Medical Association to provide continuing medical education for physicians. CoxHealth designates this live activity for a maximum of 9.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Cox Education Center is an approved provider of continuing nursing education by the Midwest Multistate Division, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. There will be 9.75 contact hours.
Day 1 will be 5.0, Day 2 will be 4.75
CoxHealth has approved this program for 9 STEMI contact hours for CoxHealth physicians and employees. Day 1 is 5.0 hours and Day 2 is 4.0 hours.
For questions regarding educational credit please contact Lisa Boyer, RN, BSN, Enterprise Educator, Cox College, 417-269-4124 or Lisa.firstname.lastname@example.org.
Accreditation approval only refers to this educational activity and does not imply endorsement of any commercial products by CoxHealth or any other proprietary entity producing health care goods or services.
Requirements for Successful Completion:
- Sign in at the registration desk.
- Complete your online evaluation form each day
On Line evaluations and certificate of attendances:
- At the completion of your on line evaluation your specific Certificate will automatically generate for you to print or save to your cell phone
Cancellations received in writing to email@example.com by September 6, 2017, will be entitled to a full refund. After this time, a $25 processing fee will be withheld. No refunds will be made the day of the conference. No shows will be charged the full conference fee.
In the event Cardiovascular Services cancels or reschedules this conference, participants are entitled to a full refund.
CoxHealth is not responsible for travel, hotel, booking fees or other cancellation fees for registrants when an activity is cancelled.
FREE to all Cox Medical Group providers. FREE to all Physicians in Residency.
Independent Physicians – $125. Nurses (limited to 60 registrations) $50
Day of registration will be $175 and taken at the door. Registration fee includes electronic syllabus, lunch dinner, and breaks.
Special rates are available for CoxHealth Heart and Vascular Summit conference participants at the University Plaza Hotel and Convention Center. Cost per room is $94 – $129 per night. Rooms are subject to availability so make your reservations early.
University Plaza Hotel
333 S. John Q. Hammons Parkway
Springfield, Mo 65802
Stuart Clark is a Senior Director and a national spokesperson for The Advisory Board Company, a for-profit, publicly-traded research firm serving more than 2,600 of America’s leading hospitals and health systems. In this capacity, he presents the firm’s findings on frontier strategic and clinical best practices.
Dr. Steven Rowe is board certified in internal medicine, cardiovascular disease, and interventional cardiology. He is currently Medical Director of Clinical Research for CoxHealth. He received his medical degree from the University of Missouri, School of Medicine. Dr. Rowe completed a cardiology fellowship at Baylor College of Medicine, Houston, Texas. He practiced and performed research at St. Luke’s Hospital in Kansas City for many years prior to his move to Springfield. Dr. Rowe has published in numerous peer-reviewed journals.
Dr. Steven Rowe, Has indicated he has an affiliation with the following companies by way of research only (there were no immediate family conflicts noted): Berlax Laboratories, Inc., Vitatron/Medtronic, Boston Scientific Corporation, Pfizer, and Velocimed, Inc. Dr. Rowe has indicated he does not intend to discuss any uses of pharmaceutical products or medical devices not approved by the FDA. He will give a balanced view of therapeutic options, and will use generic names to contribute to impartiality during the planning process. Potential conflicts have been reviewed and there were no conflicts identified that would exclude him.
Dr. Stephen Kuehn is board certified in internal medicine and interventional cardiology. He completed his medical degree at the University of Missouri in Columbia, Missouri. He completed his fellowship in cardiac and vascular interventions at Saint Louis University in St. Louis, Missouri and his interventional cardiology fellowship at St. Vincent’s Hospital in Indianapolis, Indiana. Dr. Kuehn is also the current Director of the Cardiac Catheterization Lab at Cox South.
Dr. Sarah Billings is board certified as an Ambulatory Care Pharmacist by the Board of Pharmacy Specialties and is certified as a Diabetes Educator with the National Certification Board for Diabetes Educators. She completed her doctor of pharmacy degree at the University of Missouri Kansas City School of Medicine.
Dr. Randy Mullins, is board certified in general and vascular surgery practicing at Ferrell-Duncan Clinic. He completed his medical degree and his residency at the University of Oklahoma College of Medicine. He completed his fellowship at the Mayo Clinic for vascular surgery and the Royal Adelaide Hospital in Adelaide Australia for Endovascular Surgery.
Dr. Zak Schmittling is board certified in surgery and vascular surgery practicing at Ferrell-Duncan Clinic. He earned his medical degree at Southern Illinois University School of Medicine. He completed his Residency and Internship at Baylor College of Medicine and his Fellowship at Southern Illinois University School of Medicine.
Dr. Robert Vorhies is board certified in vascular and endovascular surgery practicing at Ferrell-Duncan Clinic. He completed his Residency at University of Kansas at Wichita. He was selected to the Society of Vascular Surgery.
Dr. Vorhies, Has indicated he has an affiliation with the following companies by way of Medical Faculty consultant only (there were no immediate family conflicts noted): Cardiovascular systems INC Dr. Vorhies has indicated he does not intend to discuss any uses of pharmaceutical products or medical devices not approved by the FDA. He will give a balanced view of therapeutic options, and will use generic names to contribute to impartiality during the planning process. Potential conflicts have been reviewed and there were no conflicts identified that would exclude him.
Dr. Sridevi Pitta is board certified in interventional cardiology, cardiac diseases, and endovascular medicine. She completed her medical degree at Kurnool Medical College in Kurnool, India. Her internal medicine and cardiology fellowships were completed at Wayne State University in Detroit, Michigan and her interventional cardiology fellowship was completed at Mayo Clinic in Rochester, Minnesota. Dr. Pitta has published in numerous peer-reviewed journals.
Dr. John Garner is board certified in Clinical Cardiac Electrophysiology practicing at Ferrell-Duncan Clinic. He completed his medical degree at the University of Iowa in Iowa City, Iowa. His internal medicine internship and residency were completed at the University of Colorado Health Sciences Center in Denver, Colorado. Dr. Garner completed his cardiovascular fellowship at Baylor University Medical Center in Dallas, Texas and his EP fellowship at Indiana University School of Medicine.
Lisa Boyer, RN, BSN
Education Center, CoxHealth
Physician Relations Manager
CoxHealth Business Connections
Eric Cantrell, RN, BSN, CCRn
Cardiac Cath Lab Manager
Cardiac Catheterization Lab
James Ceaser, MD, FACS
Medical Director Cardiovascular Services
Ferrell Duncan Clinic
Leah Cook, RN, BSN, BS, CCRN
STEMI Program Coordinator
Julia Flax, MD
AAFP Credit Planner
Regional Services, CoxHealth
Bo Kim, RCCS, RCS
Cardiovascular Services Coordinator
Triesa Massey, MHA
Medical Staff Education Coordinator
Morgan Nemeth, RN
Cardiovascular Services Nurse Educator
Kathryn Pallister, ASN, CCRN
Kristyn Richner, BSAS
Vein Center Coordinator
Chris Schulze, RN, BSN
Director of Clinical Research
Center for Research and Innovation
Becky Watts, RN, BSN, MHA
All planning committee members listed with the exception of those below have indicated they (or their immediate family members) do not have any conflicts of interest or significant financial affiliations with any pharmaceutical or medical device companies that would exclude them from the planning of this activity. Planning committee members and speakers have created this activity without bias or influence from all external commercial entities. There were no conflicts identified that would exclude them from the planning process.
Planning committee member, Lisa, Boyer, RN, has indicated she is a stockholder in the following companies: Express Scripts Holding Company, Humana Incorporated, Pertola, and Johnson and Johnson. She has indicated that she does not intend to discuss any uses of pharmaceutical products or medical devices not approved by the FDA. Mrs. Boyer also indicated she would give a balanced view of therapeutic options, and will use generic name to contribute to impartiality during the planning process. There was no conflict identified that would exclude her from the planning process.